Cardiac Implantable Electronic Device (CIED) are implantable medical devices that monitor and treat cardiac arrhythmias or abnormalities in heart rate and rhythm. CIED such as pacemakers, implantable cardioverter defibrillators (ICD) and cardiac resynchronization therapy (CRT) deliver electrical therapy such as pacing pulses or defibrillation shocks to regulate abnormal heart rhythms. With increase in chronic diseases due to lifestyle changes and growing geriatric population, the demand for CIED is increasing.
The global Cardiac Implantable Electronic Device Market is estimated to be valued at US$ 32.38 Mn in 2024 and is expected to exhibit a CAGR of 2.2% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The rising adoption of remote monitoring services for CIED devices is one of the key trends driving the cardiac implantable electronic device market growth. Remote monitoring enables continuous data collection of patient’s device and heart condition transmitted through secure connection. This allows timely detection of any issues and prevent hospital visits. It also helps physician to take corrective measures proactively. During the ongoing COVID-19 pandemic, remote monitoring gained significant importance as it reduces exposure risks for high-risk cardiac patients. Going forward, major players are focusing on development of innovative remote monitoring platforms integrated with analytics capabilities which is expected to further accelerate the market growth over the forecast period.
Segment Analysis
The global Cardiac Implantable Electronic Device market is dominated by the pacemakers sub-segment, which accounts for over 30% share of the overall market. Pacemakers are the most widely used cardiac implantable electronic devices owing to the rising prevalence of arrhythmias and technological advancements in pacemaker technology. Integrated pacemakers that combine cardiac resynchronization therapy, implantable cardioverter defibrillators, and pacemaker functions into single devices are gaining popularity.
Key Takeaways
The global Cardiac Implantable Electronic Device market is expected to witness high growth over the forecast period of 2024 to 2031. Rapidly aging populations and the subsequent rise in cardiovascular diseases across major markets will drive the demand for cardiac implantable electronic devices. The global Cardiac Implantable Electronic Device Market is estimated to be valued at US$ 32.38 Mn in 2024 and is expected to exhibit a CAGR of 2.2% over the forecast period 2024 to 2031.
Regional analysis
North America currently dominates the global market and is expected to maintain its leading position during the forecast period as well. This can be attributed to the high penetration of cardiac implantable devices and availability of favorable reimbursement policies in the region. Meanwhile, the Asia Pacific region is poised to witness the fastest growth due to growing healthcare expenditures, rising awareness regarding cardiac devices, and improving access to healthcare facilities.
Key players
Key players operating in the Cardiac Implantable Electronic Device market are Boston Scientific Corporation, GlaxoSmithKline plc., Johnson & Johnson, Viatris, and Medtronic Plc. Boston Scientific holds the leading market share owing to its robust product portfolio and global sales network. Medtronic also has a significant presence with its broad range of pacemakers, implantable cardioverter defibrillators, and cardiac resynchronization therapy devices.
Get more insights on this topic: https://www.newsstatix.com/cardiac-implantable-electronic-device-market-share-and-opportunity-analysis/
The Global Implantable Cardiac Monitor Market held USD 521.41 million in 2019 and is predicted to reach USD 1,179.10 million by 2030 with a CAGR of 7.7% from 2020-2030.The implantable cardiac monitor is also known as the implantable loop recorder.
The implantable cardiac monitor technology eliminates the need for bulks external monitors that require wire leads attached to the patient.
This has boosted the implantable cardiac monitor market size.Access Full Description of this report at:- https://www.nextmsc.com/report/implantable-cardiac-monitor-market Top Companies: General Electric Company, Koninklijke Philips N.V., Abbott Laboratories, Biotronik SE & Co. KG, LivaNova PLC, Medtronic plc, Nihon Kohden Corporation, Boston Scientific Corporation, Edwards Lifescience Corporation, Phoenix Heart Center and others.The implantable cardiac monitor market is segmented on the basis of indication, end user, and geography.
On the basis of end user, the market covers hospitals, cardiac centers & clinics, ambulatory surgical centers.
Geographic breakdown and analysis of each of the aforesaid segments include regions comprising North America, Europe, Asia-Pacific, and RoW.Request free sample copy of this report at:- https://www.nextmsc.com/Implantable-Cardiac-Monitor-Market/request-sample North America denotes a higher adoption of the implantable cardiac monitor and is anticipated to hold the highest implantable cardiac monitor market share during the forecast period.
This is attributable to the factors including the high adoption rate of technologically advanced implantable cardiac monitors, the presence of major key healthcare companies, high consumer awareness, and favorable reimbursement framework.
